Hookipa Pharma
Price & Volume
Stats
See more52W Range | $0.72-$10.50 |
Market Cap | $21.2M |
Shares Short | 29,869 |
Financials
See moreRevenue (12 Mos) | $43.9M |
Revenue Growth (YoY) | -81.7% |
Gross Profit (12 Mos) | -$23.1M |
Diluted EPS | -$5.85 |
News
See moreYahoo Finance • 2 years ago
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus
Yahoo Finance • 2 years ago
HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Yahoo Finance • 2 years ago
HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023
Yahoo Finance • 2 years ago
HOOKIPA Pharma to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 9, 2023
About
CEO | Dr. Malte Peters M.D. |
CFO | Ms. Mary Theresa Coelho M.B.A. |
Address | 350 Fifth Avenue, New York, NY, United States, 10118 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 82 |
